 Varicella vaccine VARIVAX healthy children adolescents results clinical trials total healthy children adolescents months years production lots live attenuated varicella vaccine VARIVAX plaque-forming units dose vaccine Ninety-six percent vaccinees vaccination antibody glycoprotein-based enzyme-linked immunosorbent assay antibody year vaccination incidence varicella household exposure vaccinees contact results infection vaccinees varicella vaccination modified disease